Stockholm and The Woodlands, Texas (September 29, 2015) - RaySearch Laboratories AB (publ) announced today that The US Oncology Network, one of America’s largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care, has selected RayStation® to be offered throughout The US Oncology Network as one of the available radiation therapy treatment planning systems.
The US Oncology Network is comprised of more than 350 sites of care and approximately 1,000 independent, community-based physicians who treat more than 800,000 patients annually. 90 sites are radiation oncology facilities and about 140 physicians specialize in radiation oncology. Many of the centers offer a complete array of treatments to give patients a continuity of care that is state-of-the-art, yet cost effective. Physicians throughout The Network collaborate and take part in programs to assure that they are optimizing treatment possibilities.
“We initiated an effort almost two years ago to assess treatment planning solutions being developed in the marketplace,” said Jeff Limmer, Director of Medical Physics and Quality, The US Oncology Network. “In this era of quickly emerging technologies, it is extremely important to continually assess projected capability, and then to plan, in both clinically and fiscally responsible ways, for the incorporation of tools and resources which provide high quality care for patients. RayStation® will be key in helping us achieve our goals.”
Marc Mlyn, president and CEO of RaySearch’s U.S. sales organization, RaySearch Americas, Inc., said, “There was a great deal of time and effort spent analyzing RayStation® as a product and RaySearch as a company to be sure that practices in The US Oncology Network could achieve a high level of efficiency through centralized planning and remote access, and just as importantly that we had the ability to provide them with advanced technologies for the future. This is about a collaboration to put great technology into the hands of the practitioners in this very large network. We look forward to a long and successful future with them.”
Johan Löf, president and CEO of RaySearch, added, “It is satisfying to see that we are making our way into not only stand-alone centers and University Hospitals, but also into strategic and coordinated networks of community-based practices. This is a strong indicator that we are providing the products and services necessary to solidify our position as one of the leading suppliers of treatment planning systems in the U.S. market.”
Radiation therapy departments in The US Oncology Network now have the opportunity to select RayStation® as their treatment planning system. The first purchase made was at the Texas Center for Proton Therapy in June of 2015, previously announced.
About The US Oncology Network
The US Oncology Network is one of the nation’s largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. A physician-led organization, The US Oncology Network unites like-minded physicians and clinicians around a common vision of improving patient outcomes and quality of life. Leveraging healthcare information technology, shared best practices, evidence-based guidelines and quality measurements, physicians within The US Oncology Network are pioneering new ways to achieve this vision. The US Oncology Network is committed to strengthening patient access to integrated care in local communities across the nation, including collaboration with a variety of payers, hospitals and academic institutions. The US Oncology Network is supported by McKesson Specialty Health, a division of McKesson Corporation focused on empowering a vibrant and sustainable community patient care delivery system. For more information, visit www.usoncology.com.
RayStation® integrates all RaySearch’s advanced treatment planning solutions into an innovative and flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories AB (publ) is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation® treatment planning system to clinics all over the world. In addition, RaySearch’s products are distributed through licensing agreements with leading medical technology companies. RaySearch’s software solutions are used by over 2,500 clinics in more than 65 countries. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8 510 530 00
Claire Crye, The US Oncology Network
Telephone: +1(281) 825 9927